2026年全球微創青光眼手術（MIGS）器材市場報告

近年來，微創青光眼手術（MIGS）器材的市場規模迅速擴張，預計將以28.1%的複合年成長率成長，從2025年的8.9億美元成長到2026年的11.4億美元。過去幾年的成長被認為歸因於多種因素，例如青光眼患者數量的增加、人口老化、傳統青光眼手術的局限性、人們保護視力意識的提高以及白內障手術的日益普及。

預計未來幾年，微創青光眼手術（MIGS）器械市場將呈指數級成長，到2030年市場規模將達到27.9億美元，複合年成長率（CAGR）為24.9%。預測期內的成長要素包括青光眼患者數量增加、微創手術方案的接受度提高、門診眼科護理需求成長、對生活品質（QOL）的日益重視以及專科眼科診所的普及。預測期內的主要趨勢包括：微創青光眼手術的普及率不斷提高、早期和中期青光眼患者越來越傾向於選擇微創青光眼手術（MIGS）、MIGS與白內障手術聯合應用日益廣泛、門診和日間青光眼手術的擴展，以及對更安全、更快速的治療方法的需求不斷成長。

眼科疾病盛行率的不斷上升預計將推動微創青光眼手術（MIGS）器材在未來的發展。眼科疾病涵蓋多種影響眼睛和視力的疾病，其盛行率因生活方式改變、環境因素和人口老化而不斷上升。 MIGS器械是治療各種眼科疾病的創新工具，其主要作用是降低眼內壓（IOP），從而預防和延緩青光眼的進展。例如，根據美國政府機構國家眼科研究所（NEI）預測，到2030年，約有220萬美國人將失明或部分失明。因此，眼科疾病的上升趨勢正在推動MIGS器械市場的成長。

微創青光眼手術 (MIGS) 器械市場的主要企業正致力於開發先進的解決方案，例如緩釋藥物植入，以取代傳統的眼藥水治療。緩釋植入可永續釋放藥物，進而提高患者依從性，減少用藥頻率，並增強治療效果。例如，2024 年 2 月，總部位於美國的特種材料製造商塞拉尼斯公司 (Celanese Corporation) 與 Glaucos Pharmaceuticals 合作，利用塞拉尼斯公司的 VitalDose® 乙烯-醋酸乙烯酯植入(EVA) 平台，商業性推出 iDose® TR（曲伏前列素房水植入物）。這款創新產品透過將曲伏前列素直接輸送到眼內數月，取代了傳統的眼藥水治療方法。 iDose® TR 與 Glaucos 的 MIGS（微創青光眼手術）產品組合相整合，提供了一種微創治療方案，可減少每日使用眼藥水的需求，提高患者依從性，並有助於持續控制眼壓，最終有助於改善長期治療效果。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球微創青光眼手術（MIGS）器材市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 生物技術、基因組學和精準醫學
  • 工業4.0和智慧製造
  • 數位化、雲端運算、巨量資料、網路安全
  • 人工智慧（AI）和自主人工智慧
  • 物聯網、智慧基礎設施和互聯生態系統
• 主要趨勢
  • 擴大微創青光眼手術的應用
  • 早期和中期青光眼患者越來越傾向於選擇微創青光眼手術（MIGS）。
  • 微創青光眼手術合併白內障手術的增加
  • 擴大門診及當日青光眼手術
  • 對更安全、恢復更快的青光眼治療方案的需求日益成長

第5章 終端用戶產業市場分析

• 眼科診所
• 門診手術中心
• 醫院
• 專業眼科醫院
• 眼科中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球微創青光眼手術（MIGS）器材市場：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 全球微創青光眼手術（MIGS）器材市場規模、比較及成長率分析
• 全球微創青光眼手術（MIGS）器材市場表現：規模與成長，2020-2025年
• 全球微創青光眼手術（MIGS）器材市場預測：規模與成長，2025-2030年，2035年

第8章 全球潛在市場總量（TAM）

第9章 市場細分

• 依產品類型
• 小梁網微支架、結膜下微引流管、脈絡膜上腔支架、施萊姆氏管成形術及施萊姆氏管裝置
• 透過手術途徑
• 微創青光眼手術合併白內障手術，或單獨進行微創青光眼手術
• 透過目標解剖路徑
• 小梁網、施萊姆氏管、脈絡膜上腔、結膜下腔
• 按治療類型
• 內視鏡微創青光眼手術（Ab-Interno MIGS）、外視鏡微創青光眼手術（Ab-Externo MIGS）
• 最終用戶
• 眼科診所、門診手術中心（ASC）和專科眼科醫院
• 按類型細分：小梁網狀微支架
• 單腔小梁網微支架、多腔小梁網微支架、支架式小梁網支架、藥物釋放型小梁網微支架
• 依類型細分：結膜下微型引流管
• 凝膠基微型引流管、聚合物基微型引流管、膠原蛋白基微型引流管、固定管腔結膜下微型引流管
• 依類型細分：脈絡膜上腔支架
• 被動式脈絡膜上腔支架、血流控制型脈絡膜上腔支架、生物相容性聚合物脈絡膜上腔支架
• 按類型細分：施累姆氏管道成形術和施累姆氏管道裝置
• 微導管型施累姆氏管成形裝置、黏彈擴張/施累姆氏管擴張器、無植入累姆氏管成形系統、施累姆氏管支架裝置

第10章 區域與國家分析

• 全球微創青光眼手術（MIGS）器材市場：區域表現及預測，2020-2025年、2025-2030年、2035年
• 全球微創青光眼手術（MIGS）器材市場：國家、績效及預測，2020-2025年、2025-2030年、2035年

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 微創青光眼手術（MIGS）器材市場：競爭格局及市場佔有率，2024年
• 微創青光眼手術（MIGS）器材市場：公司估值矩陣
• 微創青光眼手術（MIGS）器材市場：公司概況
  • Glaukos Corporation
  • Sight Sciences Inc.
  • Alcon Inc.
  • Johnson & Johnson Vision Care Inc.
  • Bausch & Lomb Incorporated

第37章：其他領先和創新企業

• Carl Zeiss Meditec AG, Nova Eye Medical Limited, iSTAR Medical SA, New World Medical Inc., MicroSurgical Technology Inc., ASICO LLC, Ziemer Ophthalmic Systems AG, Ellex Medical Lasers Ltd., Lumenis Ltd., Iridex Corporation, Katena Products Inc., Oertli Instrumente AG, Sifi SpA, Aquesys Inc., Beaver-Visitec International

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年微創青光眼手術（MIGS）器材市場：提供新機會的國家
• 2030年微創青光眼手術（MIGS）器材市場：充滿新機會的細分市場
• 2030年微創青光眼手術（MIGS）器材市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

Minimally invasive glaucoma surgery (MIGS) devices are medical tools designed to lower intraocular pressure (IOP) in glaucoma patients using less invasive techniques compared to traditional glaucoma surgeries. These devices aim to reduce complications, shorten recovery times, and improve patient outcomes by providing a safer, less invasive surgical option for managing glaucoma.

The main types of MIGS devices include valves, glaucoma drainage implants, glaucoma tube shunts, stents, and others. A glaucoma drainage implant, also known as an aqueous shunt or tube shunt, is a small device surgically placed in the eye to treat glaucoma. These devices are used in various surgeries, such as those for glaucoma combined with cataracts or stand-alone glaucoma procedures, targeting areas such as the trabecular meshwork and suprachoroidal space. They are distributed through various channels, including direct tender and retail sales, and are utilized by end users such as ophthalmology clinics and ambulatory surgery centers (ASCs).

Tariffs have influenced the minimally invasive glaucoma surgery devices market by increasing costs for imported micro-implants, precision components, and specialized surgical instruments. These effects are most pronounced in north america and asia-pacific, where many MIGS devices are manufactured or sourced internationally. Higher device costs have impacted pricing strategies for ophthalmology clinics and ambulatory surgery centers. At the same time, tariffs have encouraged localized manufacturing, supplier diversification, and regional assembly of MIGS devices, supporting long-term supply stability.

The minimally invasive glaucoma surgery (migs) devices market research report is one of a series of new reports from The Business Research Company that provides minimally invasive glaucoma surgery (migs) devices market statistics, including minimally invasive glaucoma surgery (migs) devices industry global market size, regional shares, competitors with a minimally invasive glaucoma surgery (migs) devices market share, detailed minimally invasive glaucoma surgery (migs) devices market segments, market trends and opportunities, and any further data you may need to thrive in the minimally invasive glaucoma surgery (migs) devices industry. This minimally invasive glaucoma surgery (migs) devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The minimally invasive glaucoma surgery (migs) devices market size has grown exponentially in recent years. It will grow from $0.89 billion in 2025 to $1.14 billion in 2026 at a compound annual growth rate (CAGR) of 28.1%. The growth in the historic period can be attributed to increasing prevalence of glaucoma, growing aging population, limitations of conventional glaucoma surgeries, rising awareness of vision preservation, increasing adoption of cataract surgeries.

The minimally invasive glaucoma surgery (migs) devices market size is expected to see exponential growth in the next few years. It will grow to $2.79 billion in 2030 at a compound annual growth rate (CAGR) of 24.9%. The growth in the forecast period can be attributed to expanding glaucoma patient pool, growing acceptance of minimally invasive surgical options, rising demand for outpatient ophthalmic procedures, increasing focus on quality-of-life outcomes, expanding access to specialized ophthalmology clinics. Major trends in the forecast period include rising adoption of minimally invasive glaucoma procedures, growing preference for MIGS in early and moderate glaucoma, increasing use of MIGS in combination with cataract surgery, expansion of outpatient and ambulatory glaucoma surgeries, growing demand for safer and faster-recovery glaucoma treatments.

The increasing prevalence of eye disorders is anticipated to drive the growth of minimally invasive glaucoma surgery (MIGS) devices in the future. Eye disorders cover a wide range of conditions affecting the eyes and vision, with their prevalence rising due to lifestyle changes, environmental factors, and aging populations. MIGS devices are innovative tools used to manage various eye diseases, primarily by reducing intraocular pressure (IOP) to prevent or control the progression of glaucoma. For example, according to the National Eye Institute, a US-based government agency, approximately 2.2 million Americans will be blind or partially blind by 2030. Consequently, the growing prevalence of eye disorders is propelling the MIGS devices market.

Leading companies in the minimally invasive glaucoma surgery (MIGS) devices market are focusing on developing advanced solutions, such as sustained-release drug-delivery implants, to replace conventional topical glaucoma treatments. A sustained-release implant is a device that delivers medication continuously over time, improving patient adherence, reducing dosing frequency, and enhancing treatment effectiveness. For example, in February 2024, Celanese Corporation, a US-based specialty materials company, partnered with Glaukos to commercially launch the iDose(R) TR (Travoprost Intracameral Implant) using Celanese's VitalDose(R) Ethylene Vinyl Acetate (EVA) platform. This innovation replaces traditional eye-drop regimens by providing continuous intraocular delivery of travoprost directly to the eye over several months. Integrated with Glaukos' MIGS portfolio, it offers a minimally invasive treatment option that reduces the need for daily eye drops, improves patient compliance, and supports sustained intraocular pressure control, ultimately enhancing long-term therapeutic outcomes.

In July 2024, Alcon Inc., a Switzerland-based medical device company, acquired BELKIN Vision Inc. for $81 million. This strategic acquisition is intended to boost the global adoption of Direct Selective Laser Trabeculoplasty (DSLT) as a first-line treatment for glaucoma. BELKIN Vision Inc., an Israel-based medical device company, specializes in developing and manufacturing laser therapy devices for glaucoma treatment.

Major companies operating in the minimally invasive glaucoma surgery (migs) devices market are Glaukos Corporation, Sight Sciences Inc., Alcon Inc., Johnson & Johnson Vision Care Inc., Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Nova Eye Medical Limited, iSTAR Medical SA, New World Medical Inc., MicroSurgical Technology Inc., ASICO LLC, Ziemer Ophthalmic Systems AG, Ellex Medical Lasers Ltd., Lumenis Ltd., Iridex Corporation, Katena Products Inc., Oertli Instrumente AG, Sifi S.p.A., Aquesys Inc., Beaver-Visitec International

North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (migs) devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the minimally invasive glaucoma surgery (migs) devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The minimally invasive glaucoma surgery (MIGS) devices market consists of revenues earned by entities by providing canal-based procedures, viscocanalostomy, and canaloplasty procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The minimally invasive glaucoma surgery (MIGS) devices market also includes sales of glaucoma drainage implants, glaucoma tube shunts, and invasive devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses minimally invasive glaucoma surgery (migs) devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for minimally invasive glaucoma surgery (migs) devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The minimally invasive glaucoma surgery (migs) devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Trabecular Micro-Stents; Subconjunctival Micro-Shunts; Suprachoroidal Stents; Canaloplasty & Schlemm's Canal Devices
• 2) By Surgical Approach: MIGS in Conjunction with Cataract Surgery; Stand-Alone MIGS Procedures
• 3) By Target Anatomical Pathway: Trabecular Meshwork; Schlemm's Canal; Suprachoroidal Space; Subconjunctival Space
• 4) By Procedure Type: Ab-Interno MIGS; Ab-Externo MIGS
• 5) By End User: Ophthalmology Clinics; Ambulatory Surgery Centers (ASCs); Specialized Eye Hospitals
• Subsegments:
• 1) By Trabecular Micro-Stents: Single-Lumen Trabecular Micro-Stents; Multi-Lumen Trabecular Micro-Stents; Scaffold-Based Trabecular Stents; Drug-Eluting Trabecular Micro-Stents
• 2) By Subconjunctival Micro-Shunts: Gel-Based Micro-Shunts; Polymer-Based Micro-Shunts; Collagen-Based Micro-Shunts; Fixed-Lumen Subconjunctival Micro-Shunts
• 3) By Suprachoroidal Stents: Passive Suprachoroidal Stents; Flow-Regulated Suprachoroidal Stents; Biocompatible Polymer Suprachoroidal Stents
• 4) By Canaloplasty & Schlemm's Canal Devices: Microcatheter-Based Canaloplasty Devices; Viscodilation & Schlemm's Canal Expanders; Implant-Free Canaloplasty Systems; Schlemm's Canal Scaffolding Devices
• Companies Mentioned: Glaukos Corporation; Sight Sciences Inc.; Alcon Inc.; Johnson & Johnson Vision Care Inc.; Bausch & Lomb Incorporated; Carl Zeiss Meditec AG; Nova Eye Medical Limited; iSTAR Medical SA; New World Medical Inc.; MicroSurgical Technology Inc.; ASICO LLC; Ziemer Ophthalmic Systems AG; Ellex Medical Lasers Ltd.; Lumenis Ltd.; Iridex Corporation; Katena Products Inc.; Oertli Instrumente AG; Sifi S.p.A.; Aquesys Inc.; Beaver-Visitec International
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Minimally Invasive Glaucoma Procedures
  • 4.2.2 Growing Preference For MIGS In Early And Moderate Glaucoma
  • 4.2.3 Increasing Use Of MIGS In Combination With Cataract Surgery
  • 4.2.4 Expansion Of Outpatient And Ambulatory Glaucoma Surgeries
  • 4.2.5 Growing Demand For Safer And Faster-Recovery Glaucoma Treatments

5. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis Of End Use Industries

• 5.1 Ophthalmology Clinics
• 5.2 Ambulatory Surgery Centers
• 5.3 Hospitals
• 5.4 Specialty Eye Hospitals
• 5.5 Eye Care Centers

6. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Segmentation

• 9.1. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Trabecular Micro-Stents, Subconjunctival Micro-Shunts, Suprachoroidal Stents, Canaloplasty & Schlemm's Canal Devices
• 9.2. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgical Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• MIGS in Conjunction with Cataract Surgery, Stand-Alone MIGS Procedures
• 9.3. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Trabecular Meshwork, Schlemm's Canal, Suprachoroidal Space, Subconjunctival Space
• 9.4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Procedure Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Ab-Interno MIGS, Ab-Externo MIGS
• 9.5. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Ophthalmology Clinics, Ambulatory Surgery Centers (ASCs), Specialized Eye Hospitals
• 9.6. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Sub-Segmentation Of Trabecular Micro-Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Single-Lumen Trabecular Micro-Stents, Multi-Lumen Trabecular Micro-Stents, Scaffold-Based Trabecular Stents, Drug-Eluting Trabecular Micro-Stents
• 9.7. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Sub-Segmentation Of Subconjunctival Micro-Shunts, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Gel-Based Micro-Shunts, Polymer-Based Micro-Shunts, Collagen-Based Micro-Shunts, Fixed-Lumen Subconjunctival Micro-Shunts
• 9.8. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Sub-Segmentation Of Suprachoroidal Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Passive Suprachoroidal Stents, Flow-Regulated Suprachoroidal Stents, Biocompatible Polymer Suprachoroidal Stents
• 9.9. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Sub-Segmentation Of Canaloplasty & Schlemm's Canal Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Microcatheter-Based Canaloplasty Devices, Viscodilation & Schlemm's Canal Expanders, Implant-Free Canaloplasty Systems, Schlemm's Canal Scaffolding Devices

10. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Regional And Country Analysis

• 10.1. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 11.1. Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 12.1. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 13.1. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 14.1. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 15.1. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 16.1. Indonesia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 17.1. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 18.1. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 19.1. South East Asia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 20.1. Western Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 21.1. UK Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 22.1. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 23.1. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 24.1. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 25.1. Spain Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 26.1. Eastern Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 27.1. Russia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 28.1. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 29.1. USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 30.1. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 31.1. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 32.1. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 33.1. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

• 34.1. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product Type, Segmentation By Surgical Approach, Segmentation By Target Anatomical Pathway, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Regulatory and Investment Landscape

36. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Competitive Landscape And Company Profiles

• 36.1. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Company Profiles
  • 36.3.1. Glaukos Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Sight Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Alcon Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Johnson & Johnson Vision Care Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Bausch & Lomb Incorporated Overview, Products and Services, Strategy and Financial Analysis

37. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Other Major And Innovative Companies

• Carl Zeiss Meditec AG, Nova Eye Medical Limited, iSTAR Medical SA, New World Medical Inc., MicroSurgical Technology Inc., ASICO LLC, Ziemer Ophthalmic Systems AG, Ellex Medical Lasers Ltd., Lumenis Ltd., Iridex Corporation, Katena Products Inc., Oertli Instrumente AG, Sifi S.p.A., Aquesys Inc., Beaver-Visitec International

38. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

40. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market High Potential Countries, Segments and Strategies

• 40.1 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer